The increase in type 1 interferons is also seen in C9ORF72 ALS and FTD patients, supporting the critical role of C9ORF72 in repressing excessive inflammation in myeloid cells in FTD and ALS (McCauley et al., 2020). The gene discussed is C9orf72; the disease is frontotemporal dementia.